News | January 06, 2009

Medrad Sponsors PET Study at University of Zurich

January 6, 2009 - MEDRAD has agreed to collaborate with the University of Zurich in a study on dynamic PET imaging with the MEDRAD Intego PET Infusion System, in which researchers will utilize MEDRAD’s system for controlling the radioactive dose delivered during PET imaging procedures.

The study will examine patients with tumors in the chest or abdomen and compare standard quantitative techniques, such as standard uptake value (SUV), with more advanced kinetic and compartmental models. One of the primary goals of the research is to explore how controlled delivery technology can enable dynamic imaging by providing additional clinical utility and making these advanced techniques more practical. By enabling the benefit of repeatable infusion of the prescribed FDG dose to all subjects in the study, the Intego System is a key element in the research.

“The research will explore the clinical viability of dynamic imaging with PET,” said Alfred Buck, M.D., University of Zurich (Switzerland). The University of Zurich is a leading institution in dynamic PET research, and has licensed its proprietary FDG delivery technology to MEDRAD for use in the Intego PET Infusion System.

The Intego System is designed to automatically extract a patient dose from a multi-dose vial and delivers it directly to the patient, virtually eliminating manual dose preparation and handling, and the corresponding radiation exposure to the technologist inherent in manual preparation. With the Intego System’s dose-on-demand capability, the prescribed dose can be delivered when the patient and clinician are ready. This should enable the clinician to respond to schedule changes, patient delays and add-on patients.

The system’s features include real-time dose availability information, an integrated ionization chamber and an optional weight-based dose calculation, that allow the healthcare provider to more precisely customize each patient’s dose. Safety features include a tungsten multi-dose vial shield, a fully lead-lined mobile cart, and an automated saline flush to remove residual FDG from the line after each infusion.

For more information: www.medrad.com

Related Content

ACR Offers Revised Contrast Media in Imaging Manual
News | Contrast Media | July 17, 2017
The American College of Radiology (ACR) recently revised its authoritative guide for the safe and effective use of...
Sponsored Content | Case Study | Contrast Media Injectors | April 13, 2017
The volume of computed tomography (CT) imaging exams continues to grow in the United States,[2] adding pressure to...
contrast media
Feature | Contrast Media Injectors | March 02, 2017 | By Jeff Zagoudis
With medical imaging use on the rise, contrast media use is expected to grow as well, according to a May 2016 report...
contrast media
News | Contrast Media | December 09, 2016
At the 2016 Annual Meeting of the Radiological Society of North America (RSNA 2016), Bracco Diagnostics Inc. showcased...
GlobalData, contrast media injectors market,
News | Contrast Media Injectors | May 03, 2016
The global market for contrast media injectors is set to increase from $830 million in 2015 to almost $1.8 billion by...
CTA, CT, contrast media injector, contrast injector, EmpowerCTA

Bracco's new EmpowerCTA+, designed for cardiac CT angiography exams.

Feature | Contrast Media Injectors | April 29, 2016 | Jeff Zagoudis
The biggest trend in contrast media injector technology today is one seen throughout all of healthcare — doing more...
Guerbet, OptiOne single-head contrast delivery system, FDA 510k clearance
Technology | Contrast Media Injectors | February 16, 2016
February 16, 2016 — Guerbet announced that it has received 510K clearance from the U.S.
News | Contrast Media | November 29, 2015
November 29, 2015 — Guerbet announced that it has completed its acquisition of the "contrast media and delivery syste
Galt Medical, Health Line International Corp., Nexus CT Midline Catheter with MST Insertion Kit

Image courtesy of Galt Medical

Technology | Contrast Media Injectors | October 01, 2015
October 1, 2015 — Galt Medical has partnered with Health Line International Corp.
Technology | March 06, 2015
Bracco Imaging, through its business unit Bracco Injeneering SA, announced the availability of its EmpowerCTA+, an...
Overlay Init